Advertisement

Related Videos

Opening Session Panel Discussion

Sarah Yim, MD, on Clinical Development of Biosimilars: Lessons for Interventional Pharmacoeconomics

Clinical Trial Design: Statistical Options/Challenges Panel Discussion

Amit Sanyal, MD: A Clinician’s Perspective

Javid J. Moslehi, MD, on Cardiovascular and Thrombotic Considerations of Kinase Inhibitors: The Case of BTK Inhibitors

Advertisement

Advertisement




Jun
30
Today In Oncology
Study Finds About One in Six Chemotherapy Drugs in Sub-Saharan Africa Fails Quality Tests
Partial-Breast Radiotherapy After Breast-Conserving Surgery: 10-Year Outcomes
Neoadjuvant Durvalumab Plus Chemotherapy for High-Risk Upper Tract Urothelial Carcinoma
Patterns of ICI Use and Survival Outcomes in Metastatic Colorectal Cancer
Genitourinary Oncology Highlights: Treatment Advances in Renal Cell, Bladder, Urothelial, and Prostate Cancers
View More 
Advertisement
© 2025 HSP News Service, L.L.C.
Conexiant Oncology Logo